231-765-0
Applied Filters:
Keyword:'231-765-0'
Showing 1-5 of 5 results for "231-765-0" within Technical Documents
ExPlore with Confidence: Prestige Antibodies Breast Cancer Research
infantile hemangioma:
modulation by survivin and the Hippo pathway. Laboratory Investigation 2015 95,
765–780.
2. Giraddi RR et al. Stem and progenitor cell division kinetics during postnatal mouse
mammary
White Paper - The Message in the Marks: Deciphering Cancer Epigenetics
07-1580
Anti-LSD1 09-058
Anti-MeCP2, clone 4H7 MABE328
Anti-MLL/HRX, CT., clone 9-12 05-765
Anti-MLL-C ABE240
Anti-MSL3-like 1 ABE467
Anti-NRF-1 ABE1844
Anti-Nuclear factor 1/C ABE1387
XP725 Antibody List 013M4793
NP_005096.1, M y n/d n/d
764 ZAP-70 Z0627 22637, 7535 ZAP70,Zap70 NP_033565.2,NP_997402.1 M y y n/d
765 Zip Kinase Z0134 1613 DAPK3 NP_001339.1 P y n/d n/d
766 Zyxin Z0377 22793, 114636, 7791 Zyx,ZYX NP_
XP725 Antibody List
NP_005096.1, M y n/d n/d
764 ZAP-70 Z0627 22637, 7535 ZAP70,Zap70 NP_033565.2,NP_997402.1 M y y n/d
765 Zip Kinase Z0134 1613 DAPK3 NP_001339.1 P y n/d n/d
766 Zyxin Z0377 22793, 114636, 7791 Zyx,ZYX NP_
Inhibitor Sourcebook 3rd Edition
1281.
Shuai, K., and Liu, B. 2003. Nat. Rev. Immunol. 3, 900.
Hou, S.X. et al. 2002. Dev. Cell 3, 765.
Highlighted below are inhibitors included in InhibitorSelect™JAK/STAT Signaling
Pathway Inhibitor